🇺🇸 FDA
Patent

US 8329702

Heterocycles useful as modulators of ion channels

granted A61PA61P1/00A61P1/12

Quick answer

US patent 8329702 (Heterocycles useful as modulators of ion channels) held by Vertex Pharmaceuticals Incorporated expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
13
CPC classes
A61P, A61P1/00, A61P1/12, A61P13/02, A61P19/02